Table 3.
Variables | Baseline | 12 week | 1 year | 2 year | 3 year | 4 year | 5 year | |
---|---|---|---|---|---|---|---|---|
N | SIMV | 4445 | 4371 | 4290 | 4168 | 4033 | 3930 | 775 |
ATV | 4435 | 4334 | 4198 | 4099 | 3985 | 3861 | 758 | |
LDL cholesterol (mmol/L) | SIMV | 3.14 (0.01) | 2.71 (0.01) | 2.64 (0.01) | 2.68 (0.01) | 2.75 (0.01) | 2.68 (0.01) | 2.58 (0.02) |
ATV | 3.15 (0.01) | 2.01 (0.01) | 2.05 (0.01) | 2.12 (0.01) | 2.22 (0.01) | 2.16 (0.01) | 2.07 (0.03) | |
HR | 1.14 (1.07–1.20) | 1.09 (1.03–1.16) | 1.12 (1.05–1.19) | 1.13 (1.06–1.20) | 1.10 (1.03–1.18) | 1.08 (1.01–1.16) | 1.06 (0.91–1.25) | |
Non-HDL cholesterol (mmol/L) | SIMV | 3.87 (0.02) | 3.41 (0.01) | 3.33 (0.01) | 3.36 (0.01) | 3.43 (0.01) | 3.37 (0.01) | 3.26 (0.03) |
ATV | 3.90 (0.02) | 2.59 (0.01) | 2.63 (0.01) | 2.70 (0.01) | 2.79 (0.01) | 2.74 (0.01) | 2.67 (0.03) | |
HR | 1.15 (1.08–1.21) | 1.10 (1.04–1.17) | 1.15 (1.08–1.22) | 1.18 (1.11–1.25) | 1.12 (1.04–1.20) | 1.11 (1.03–1.19) | 1.07 (0.91–1.25) | |
Apolipoprotein B (g/L) | SIMV | 1.19 (0.0) | 1.05 (0.0) | 1.07 (0.0) | 1.03 (0.0) | 1.06 (0.0) | 1.09 (0.0) | 1.08 (0.01) |
ATV | 1.19 (0.0) | 0.80 (0.0) | 0.84 (0.0) | 0.82 (0.0) | 0.86 (0.0) | 0.90 (0.0) | 0.91 (0.01) | |
HR | 1.15 (1.09–1.22) | 1.13 (1.06–1.19) | 1.17 (1.10–1.24) | 1.18 (1.11–1.26) | 1.16 (1.08–1.24) | 1.13 (1.05–1.21) | 1.07 (0.91–1.26) | |
Estimated apoB (g/L) | SIMV | 1.01 (0.0) | 0.90 (0.0) | 0.87 (0.0) | 0.88 (0.0) | 0.90 (0.0) | 0.89 (0.0) | 0.86 (0.01) |
ATV | 1.02 (0.0) | 0.69 (0.0) | 0.70 (0.0) | 0.72 (0.0) | 0.74 (0.0) | 0.73 (0.0) | 0.71 (0.01) | |
HR | 1.15 (1.09–1.21) | 1.11 (1.04–1.17) | 1.14 (1.08–1.21) | 1.17 (1.10–1.24) | 1.12 (1.05–1.20) | 1.11 (1.04–1.20) | 1.07 (0.91–1.25) |
Data are expressed as mean (SE) or HR per 1-SD (95% CI)
Adjusted for age and sex
ATV atorvastatin, SIMV simvastatin